Daito Pharmaceutical Co.,Ltd.
JP ˙ TSE ˙ JP3486150000
1.356,00 ¥ ↓ -15,00 (-1,09%)
2026-10-19
AKTIENPREIS
SecurityJP:4577 / Daito Pharmaceutical Co.,Ltd.
InstitutionDFIC - Dimensional International Core Equity 2 ETF
Latest Disclosed Ownership32,480 shares
Latest Disclosed Value $ 261,365
DFIC - Dimensional International Core Equity 2 ETF reports 12.47% increase in ownership of 4577 / Daito Pharmaceutical Co.,Ltd.

On June 29, 2026 - DFIC - Dimensional International Core Equity 2 ETF filed a NPORT-P form disclosing ownership of 32,480 shares of Daito Pharmaceutical Co.,Ltd. (JP:4577) valued at $40,957,280 USD as of April 30, 2026. The entity filed a previous NPORT-P on March 27, 2026 disclosing 28,880 shares of Daito Pharmaceutical Co.,Ltd.. This represents a change in shares of 12.47% during the quarter. The current value of the position is $44,042,880 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-06-29 2026-04-30 NP DAITO PHARMACEUTICAL EC JP3486150000 32,480 3,600 12.47 261 4.82 0.0019
2026-03-27 2026-01-31 NP DAITO PHARMACEUTICAL EC JP3486150000 28,880 0 0.00 250 6.87 0.0019
2025-12-29 2025-10-31 NP DAITO PHARMACEUTICAL EC JP3486150000 28,880 0 0.00 233 0.43 0.0021
2025-09-25 2025-07-31 NP DAITO PHARMACEUTICAL EC JP3486150000 28,880 14,440 100.00 232 10.48 0.0024
2025-06-26 2025-04-30 NP DAITO PHARMACEUTICAL EC JP3486150000 14,440 0 0.00 211 8.81 0.0024
2025-03-28 2025-01-31 NP DAITO PHARMACEUTICAL EC JP3486150000 14,440 0 0.00 194 -8.96 0.0025
2024-12-30 2024-10-31 NP DAITO PHARMACEUTICAL EC JP3486150000 14,440 0 0.00 212 -7.42 0.0031
2024-09-27 2024-07-31 NP DAITO PHARMACEUTICAL EC JP3486150000 14,440 2,000 16.08 230 15.08 0.0035
2024-06-26 2024-04-30 NP DAITO PHARMACEUTICAL EC JP3486150000 12,440 2,500 25.15 200 48.51 0.0034
2024-03-28 2024-01-31 NP DAITO PHARMACEUTICAL EC JP3486150000 9,940 1,800 22.11 134 30.10 0.0026
2023-12-28 2023-10-31 NP DAITO PHARMACEUTICAL EC JP3486150000 8,140 3,740 85.00 103 43.06 0.0025
2023-09-27 2023-07-31 NP DAITO PHARMACEUTICAL EC JP3486150000 4,400 1,400 46.67 72 30.91 0.0018
2023-06-26 2023-04-30 NP DAITO PHARMACEUTICAL EC JP3486150000 3,000 600 25.00 56 14.58 0.0017
2023-03-30 2023-01-31 NP DAITO PHARMACEUTICAL EC JP3486150000 2,400 1,100 84.62 48 118.18 0.0019
2022-12-27 2022-10-31 NP DAITO PHARMACEUTICAL EC JP3486150000 1,300 1,300 22 0.0016
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.